BR9607146A - Processo para proteger um animal de uma infecção viral e uma mulher de uma infecção transmitida através de relações sexuais vaginais para evitar o espalhamento de um patógeno viral de um indivuduo infectado a outros com bactérias transformadas para manipular a flora bacteriana mucosa de um hospedeiro e para inativar particulas vírais infecciosas em suprimentos de água suspeita e composição de matéria - Google Patents

Processo para proteger um animal de uma infecção viral e uma mulher de uma infecção transmitida através de relações sexuais vaginais para evitar o espalhamento de um patógeno viral de um indivuduo infectado a outros com bactérias transformadas para manipular a flora bacteriana mucosa de um hospedeiro e para inativar particulas vírais infecciosas em suprimentos de água suspeita e composição de matéria

Info

Publication number
BR9607146A
BR9607146A BR9607146A BR9607146A BR9607146A BR 9607146 A BR9607146 A BR 9607146A BR 9607146 A BR9607146 A BR 9607146A BR 9607146 A BR9607146 A BR 9607146A BR 9607146 A BR9607146 A BR 9607146A
Authority
BR
Brazil
Prior art keywords
infection
viral
woman
manipulate
animal
Prior art date
Application number
BR9607146A
Other languages
English (en)
Inventor
Peter Poon-Hang Lee
Original Assignee
Lee Peter Poon Hang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lee Peter Poon Hang filed Critical Lee Peter Poon Hang
Publication of BR9607146A publication Critical patent/BR9607146A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/60—Isolated nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
BR9607146A 1995-03-08 1996-03-08 Processo para proteger um animal de uma infecção viral e uma mulher de uma infecção transmitida através de relações sexuais vaginais para evitar o espalhamento de um patógeno viral de um indivuduo infectado a outros com bactérias transformadas para manipular a flora bacteriana mucosa de um hospedeiro e para inativar particulas vírais infecciosas em suprimentos de água suspeita e composição de matéria BR9607146A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/401,070 US5733540A (en) 1995-03-08 1995-03-08 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
PCT/US1996/003151 WO1996027292A1 (en) 1995-03-08 1996-03-08 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria

Publications (1)

Publication Number Publication Date
BR9607146A true BR9607146A (pt) 1997-11-25

Family

ID=23586156

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9607146A BR9607146A (pt) 1995-03-08 1996-03-08 Processo para proteger um animal de uma infecção viral e uma mulher de uma infecção transmitida através de relações sexuais vaginais para evitar o espalhamento de um patógeno viral de um indivuduo infectado a outros com bactérias transformadas para manipular a flora bacteriana mucosa de um hospedeiro e para inativar particulas vírais infecciosas em suprimentos de água suspeita e composição de matéria

Country Status (11)

Country Link
US (1) US5733540A (pt)
EP (1) EP0871363A4 (pt)
JP (1) JPH11501632A (pt)
CN (1) CN100519735C (pt)
AP (1) AP664A (pt)
AU (1) AU696449B2 (pt)
BR (1) BR9607146A (pt)
CA (1) CA2214723A1 (pt)
EA (1) EA000576B1 (pt)
OA (1) OA10741A (pt)
WO (1) WO1996027292A1 (pt)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
US5547684A (en) * 1993-02-10 1996-08-20 Pharmec Company Cosmetic composition containing a DNA-sodium salt and methods of making and using the same
GB9521568D0 (en) * 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
MXPA00008352A (es) * 1998-02-27 2002-10-17 Univ Pennsylvania Vacunas, composiciones inmunoterapeuticas y metodos para usar las mismas.
EP1100950A4 (en) * 1998-07-30 2002-10-16 Wisconsin Alumni Res Found GASTROINTESTINAL BACTERIAL ANTIBODY PLANTS
JP2002542182A (ja) * 1999-04-16 2002-12-10 オセル・インコーポレーテッド 粘膜上の可溶性ウイルス特異リガンドの半減期を増加させる方法
DK1190101T3 (da) 1999-06-24 2009-08-03 Univ Johns Hopkins Sammensætninger og fremgangsmåder til at forebygge transepithelial overförsel af HIV
WO2002060390A2 (en) 2001-01-04 2002-08-08 Yale University Induction of immune responses to isoaspartyl-modified antigens
US7780961B2 (en) * 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
US7101565B2 (en) 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
AU2003276822A1 (en) * 2002-03-08 2004-02-02 Osel, Inc. Lactobacilli expressing biologically active polypeptides and uses thereof
EP1513545B1 (en) * 2002-06-19 2008-03-19 Actogenix N.V. Methods and means to promote gut absorption
WO2004046346A2 (en) * 2002-11-15 2004-06-03 Vib Vzw Self-containing lactobacillus strain
US20090208478A1 (en) * 2003-10-24 2009-08-20 Gencia Corporation Transducible polypeptides for modifying metabolism
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
EP2418281B1 (en) 2003-10-24 2016-06-01 Gencia Corporation Methods and compositions for delivering polynucleotides
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US8877178B2 (en) * 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
ATE511848T1 (de) 2004-08-25 2011-06-15 Us Gov Health & Human Serv Lebendige mikrobielle mikrobizide
WO2006083516A2 (en) * 2005-01-12 2006-08-10 Osel, Inc. Modified cyanovirin-n polypeptide
BRPI0611492B1 (pt) * 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
AU2006253006B8 (en) * 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
CA2631598C (en) 2005-11-29 2017-06-27 Actogenix Nv Induction of mucosal tolerance to antigens
JP2010516269A (ja) 2007-01-25 2010-05-20 アクトジェニックス・エヌブイ 抗原の粘膜送達による免疫疾患の治療
MX2009008166A (es) 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
EP2273998A2 (en) * 2008-04-04 2011-01-19 Farallone Holdings Bv Methods and materials for gastrointestinal delivery of pathogen/toxin binding agents
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
PL2556150T3 (pl) * 2010-04-06 2017-05-31 Vakzine Projekt Management Gmbh Cząstka wirusowa uwalniana po zakażeniu komórek ssaczych ludzkim cytomegalowirusem (hcmv) zawierająca białko fuzyjne i jej zastosowanie
IL208820A0 (en) 2010-10-19 2011-01-31 Rachel Teitelbaum Biologic female contraceptives
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
CN103619341A (zh) 2011-04-19 2014-03-05 Arms制药有限公司 抑制有害微生物的方法及其阻隔形成组合物
EP3600365A4 (en) 2017-03-29 2021-01-06 President and Fellows of Harvard College METHOD OF REGULATING GENE EXPRESSION IN A CELL
CN111491657A (zh) 2017-10-20 2020-08-04 哈佛学院院长及董事 用于异源蛋白质生产的人工分泌肽
WO2019113096A1 (en) * 2017-12-05 2019-06-13 BioPlx, Inc. Methods and compositions to prevent microbial infection
WO2022020985A1 (zh) * 2020-07-27 2022-02-03 上海市公共卫生临床中心 利用呼吸道上皮细胞膜防治呼吸道传染病的方法及应用
EP4130258A1 (en) 2021-08-02 2023-02-08 Evonik Operations GmbH Microorganisms displaying viral decoy receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE469875C (sv) * 1991-07-25 1997-02-05 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
JPH07504817A (ja) * 1992-03-03 1995-06-01 ザ ロックフェラー ユニヴァーシティ Ｂ２９（Ｉｇ‐βまたはＩｇ−γ）を含むレセプタ複合体およびその利用
AU2976995A (en) * 1994-07-15 1996-02-16 Aalborg Industries A/S A fluid-bed heat exchanger, fluid-bed combustion reactor systems and methods for the operation of a fluid-bed heat exchanger and a fluid-bed combustion reactor system
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health

Also Published As

Publication number Publication date
CA2214723A1 (en) 1996-09-12
US5733540A (en) 1998-03-31
EP0871363A4 (en) 2001-12-12
OA10741A (en) 2002-12-11
EA000576B1 (ru) 1999-12-29
WO1996027292A1 (en) 1996-09-12
EP0871363A1 (en) 1998-10-21
CN1177909A (zh) 1998-04-01
AU696449B2 (en) 1998-09-10
CN100519735C (zh) 2009-07-29
EA199700215A1 (ru) 1998-02-26
AP664A (en) 1998-08-19
AP9701087A0 (en) 1997-10-31
JPH11501632A (ja) 1999-02-09
AU5304496A (en) 1996-09-23

Similar Documents

Publication Publication Date Title
BR9607146A (pt) Processo para proteger um animal de uma infecção viral e uma mulher de uma infecção transmitida através de relações sexuais vaginais para evitar o espalhamento de um patógeno viral de um indivuduo infectado a outros com bactérias transformadas para manipular a flora bacteriana mucosa de um hospedeiro e para inativar particulas vírais infecciosas em suprimentos de água suspeita e composição de matéria
HUP9903822A2 (hu) Polinukleotid-vakcinakészítmény sertések szaporodásbiológiai és légzőszervi kórképei ellen
ATE138384T1 (de) Olionukleotidalkylphosphonate und - phosphonothioate
BR9810745A (pt) Derivados de benzimidazol
IL153474A0 (en) Human papilloma virus treatment
BR9912653A (pt) Vìrus de herpes atenuado, cepa de vìrus, célula dendrìtica, processo para produzir um célula, composição farmacêutica, uso de um vìrus, e, processo para executar a terapia de gene em um paciente humano ou animal ou para tratar ou prevenir uma infecção patogênica ou câncer para tratar paciente animal
BR9712366A (pt) Gene de gd2 do vírus do herpes simples hsv2 isolado, plasmídeo compreendendo o mesmo, e, processos de induzir, em indivíduo, uma resposta imune contra hsv2 gd2, de tratar um indíviduo que está infectado com hsv, e, de prevenir que um indivíduo fique infectado com hsv
UA40571C2 (uk) Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
DK1042340T3 (da) 6-O-alkylerythromycinoxim-B
BR0316291A (pt) Vacina contra hcv, métodos de prevenção ou de tratamento de uma infecção por hcv em um mamìfero e de vacinação de um indivìduo, e, uso de uma vacina contra hcv
DE69922529D1 (de) Ribavirin-interferon-alpha-kombinationstherapie zur vernichtung nachweisbarer hcv-rna in chronisch hepatitis c infizierten patienten
CO5090882A1 (es) Nueva vacuna y procedimiento de uso des transmitidas sexualmente
Abbott et al. Enterobacter cancerogenus (“Enterobacter taylorae”): infections associated with severe trauma or crush injuries
BR0209251A (pt) Vacina contra vìrus da febre aftosa
ATE258375T1 (de) Behandlungen von der foulbroodbienenkrankheit
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
Muguti et al. Tetanus following human bite
Roos et al. Peritonsillar abscess in spite of adequately performed tonsillectomy
ATE326199T1 (de) Vorrichtung zur gleichzeitigen austragung von wirkstoffen in den cervikal- und vaginalkanal
ES2146574T3 (es) Secuencias de nucleotidos y polipeptidos, en particular del virus del colera del cerdo.
Nicholson et al. Septic arthritis due to Actinomyces pyogenes
BR9916473A (pt) Proteìnas de superfìcie exterior, seus genes e seu uso
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
ATE291904T1 (de) 2,4-dichlorbenzylalkohol und amylmetakresol gegen hiv-infektion
Gubler Septic arthritis of the knee induced by Pasteurella multocida and Bacteroides fragilis following an attack by a wild boar

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: SUGERE-SE O INDEFERIMENTO DO PRESENTE PEDIDO DE PATENTE DE INVENCAO COM BASE NOS ART. 10 (VIII), 15, 24 DA LEI 9.279 DE 14/05/96 E ART. 229-A DA LEI 10.196 DA 14/02/01, QUE MODIFICOU A LEI 9.279 DE MODIFICOU A LEI 9.279 DE 14/05/96.